<DOC>
	<DOCNO>NCT02783937</DOCNO>
	<brief_summary>Filgrastim Granulocyte-Colony Stimulating factor ( G-CSF ) . It FDA approve drug . Very small embryonic-like stem cell ( VSELs ) find ovary . Animal study show cell able regenerate affect ovary . Studies mice show Filgrastim result recovery oogenesis chemotherapy-induced gonadal failure ( 2013 , 2014 , 2015 ) .</brief_summary>
	<brief_title>Filgrastim Premature Ovarian Insufficiency</brief_title>
	<detailed_description>Premature ovarian insufficiency ( POI ) curative treatment . Filgrastim FDA approve Granulocyte-Colony Stimulating factor ( G-CSF ) . Very small embryonic-like stem cell ( VSELs ) find testis ovary . VSELs stem cell notice survive chemotherapy induce gonadal failure . Data animal study show stimulation stem cell result generation affect gonad . Studies mice show promising stimulate effect Filgrastim recovery spermatogenesis oogenesis chemotherapy-induced gonadal failure ( 2013 , 2014 , 2015 ) .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Primary Ovarian Insufficiency</mesh_term>
	<mesh_term>Menopause , Premature</mesh_term>
	<mesh_term>Lenograstim</mesh_term>
	<criteria>Women Premature Ovarian Insufficiency ( POI ) : For purpose research woman consider POI age less 40 year amenorrhea least 4 month FSH level 25 IU/L ( repeat twice &gt; 4 week apart ) . Abnormal karyotype Previous pelvic abdominal radiotherapy Previous surgical removal ovarian pathology Chronic disease : renal , liver , cardiac , malignancy</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Premature</keyword>
	<keyword>Ovarian</keyword>
	<keyword>Failure</keyword>
	<keyword>Filgrastim</keyword>
</DOC>